Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Houlihan Lokey (HLI) EBITDA (2016 - 2025)

Houlihan Lokey's EBITDA history spans 12 years, with the latest figure at $116.1 million for Q4 2025.

  • For Q4 2025, EBITDA rose 146.22% year-over-year to $116.1 million; the TTM value through Dec 2025 reached $504.7 million, up 54.49%, while the annual FY2025 figure was $403.0 million, 45.76% up from the prior year.
  • EBITDA reached $116.1 million in Q4 2025 per HLI's latest filing, up from $97.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $171.9 million in Q4 2021 to a low of $32.2 million in Q3 2022.
  • Average EBITDA over 5 years is $89.4 million, with a median of $87.4 million recorded in 2021.
  • Peak YoY movement for EBITDA: tumbled 69.89% in 2022, then soared 164.93% in 2024.
  • A 5-year view of EBITDA shows it stood at $171.9 million in 2021, then plummeted by 49.24% to $87.3 million in 2022, then increased by 10.45% to $96.4 million in 2023, then plummeted by 51.07% to $47.2 million in 2024, then soared by 146.22% to $116.1 million in 2025.
  • Per Business Quant, the three most recent readings for HLI's EBITDA are $116.1 million (Q4 2025), $97.7 million (Q3 2025), and $145.9 million (Q2 2025).